InvestorsHub Logo
Followers 59
Posts 4003
Boards Moderated 0
Alias Born 04/23/2013

Re: DMC8 post# 423977

Monday, 05/06/2024 6:48:37 AM

Monday, May 06, 2024 6:48:37 AM

Post# of 427500
The 1.8g capsules described in this article tells me that the drug used in this trial was EPADEL. I also assume Mochida has a MOU patent on this indication? Would this indication fall under our IP sharing contract with Mochida in the US or other territories? I’ll do some homework on this today.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News